156 related articles for article (PubMed ID: 1848519)
1. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification.
Gottschall PE; Tatsuno I; Arimura A
FASEB J; 1991 Feb; 5(2):194-9. PubMed ID: 1848519
[TBL] [Abstract][Full Text] [Related]
2. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
3. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
Tatsuno I; Gottschall PE; Arimura A
Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
[TBL] [Abstract][Full Text] [Related]
5. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
[TBL] [Abstract][Full Text] [Related]
7. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
Shivers BD; Görcs TJ; Gottschall PE; Arimura A
Endocrinology; 1991 Jun; 128(6):3055-65. PubMed ID: 2036976
[TBL] [Abstract][Full Text] [Related]
8. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: molecular identification and interaction with vasoactive intestinal peptide (VIP).
Tatsuno I; Gottschall PE; Arimura A
Peptides; 1991; 12(3):617-21. PubMed ID: 1923939
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes.
Tatsuno I; Gottschall PE; Köves K; Arimura A
Biochem Biophys Res Commun; 1990 May; 168(3):1027-33. PubMed ID: 2346475
[TBL] [Abstract][Full Text] [Related]
12. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification of receptor for pituitary adenylate cyclase activating polypeptide.
Ohtaki T; Watanabe T; Ishibashi Y; Kitada C; Tsuda M; Gottschall PE; Arimura A; Fujino M
Biochem Biophys Res Commun; 1990 Sep; 171(2):838-44. PubMed ID: 2169736
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain.
Suda K; Smith DM; Ghatei MA; Bloom SR
Neurosci Lett; 1992 Mar; 137(1):19-23. PubMed ID: 1320752
[TBL] [Abstract][Full Text] [Related]
15. Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord.
Cauvin A; Robberecht P; De Neef P; Gourlet P; Vandermeers A; Vandermeers-Piret MC; Christophe J
Regul Pept; 1991 Aug; 35(2):161-73. PubMed ID: 1661904
[TBL] [Abstract][Full Text] [Related]
16. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
18. Prohormone convertases 1 and 2 process ProPACAP and generate matured, bioactive PACAP38 and PACAP27 in transfected rat pituitary GH4C1 cells.
Li M; Shuto Y; Somogyvári-Vigh A; Arimura A
Neuroendocrinology; 1999 Mar; 69(3):217-26. PubMed ID: 10087454
[TBL] [Abstract][Full Text] [Related]
19. Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors.
Li M; Shioda S; Somogyvári-Vigh A; Onda H; Arimura A
Endocrine; 1997 Oct; 7(2):183-90. PubMed ID: 9549044
[TBL] [Abstract][Full Text] [Related]
20. Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells.
Basille M; Gonzalez BJ; Leroux P; Jeandel L; Fournier A; Vaudry H
Neuroscience; 1993 Nov; 57(2):329-38. PubMed ID: 8115042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
